Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Fibromyalgia
ADR ID BADD_A04686
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.05      Muscle disorders
15.05.02      Muscle pains
15.05.02.002      Fibromyalgia
Description A common nonarticular rheumatic syndrome characterized by myalgia and multiple points of focal muscle tenderness to palpation (trigger points). Muscle pain is typically aggravated by inactivity or exposure to cold. This condition is often associated with general symptoms, such as sleep disturbances, fatigue, stiffness, HEADACHES, and occasionally DEPRESSION. There is significant overlap between fibromyalgia and the chronic fatigue syndrome (FATIGUE SYNDROME, CHRONIC). Fibromyalgia may arise as a primary or secondary disease process. It is most frequent in females aged 20 to 50 years. (From Adams et al., Principles of Neurology, 6th ed, p1494-95) [MeSH]
MedDRA Code 10048439
MeSH ID D005356
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Fibromyalgia syndrome | Fibrositis | Muscular rheumatism | Fibromyalgia | Fibromyositis | Fibromyalgia worsened | Diffuse polyalgic syndrome | Fibromyalgias | Fibromyalgia-Fibromyositis Syndrome | Fibromyalgia Fibromyositis Syndrome | Fibromyalgia-Fibromyositis Syndromes | Syndrome, Fibromyalgia-Fibromyositis | Syndromes, Fibromyalgia-Fibromyositis | Rheumatism, Muscular | Muscular Rheumatism | Fibrositides | Myofascial Pain Syndrome, Diffuse | Diffuse Myofascial Pain Syndrome | Fibromyositis-Fibromyalgia Syndrome | Fibromyositis Fibromyalgia Syndrome | Fibromyositis-Fibromyalgia Syndromes | Syndrome, Fibromyositis-Fibromyalgia | Syndromes, Fibromyositis-Fibromyalgia | Fibromyalgia, Secondary | Fibromyalgias, Secondary | Secondary Fibromyalgia | Secondary Fibromyalgias | Fibromyalgia, Primary | Fibromyalgias, Primary | Primary Fibromyalgia | Primary Fibromyalgias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02053Sofosbuvir0.000621%
BADD_D02093Sulfasalazine--
BADD_D02145Telbivudine--
BADD_D02236Tofacitinib0.035010%
BADD_D02268Treprostinil0.000280%
BADD_D02329Valproic acid0.000100%
BADD_D02331Valsartan0.000053%
BADD_D02346Venlafaxine0.000097%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02407Upadacitinib--
BADD_D02412Octreotide--
BADD_D02436Atorvastatin0.000030%
BADD_D02443Tiotropium0.000184%
BADD_D02464Fingolimod0.002146%
BADD_D02558Gadolinium cation (3+)-
BADD_D02577Oseltamivir acid0.000843%
BADD_D02580Ozanimod0.001181%
BADD_D02595Solriamfetol0.000137%
The 3th Page    First    Pre   3    Total 3 Pages